Thrombocytopenia and thrombosis due to heparin

Cardiovascular Reviews and Reports

Volumn 19, Issue 4, 1998, Pages 38-48

  Wehrmacher, William H ^a   Messmore Jr , Harry L ^b   Lewis, Bruce ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGATROBAN; DANAPAROID; HEPARIN;

FIBRINOLYTIC THERAPY; HEPARINIZATION; HUMAN; LABORATORY TEST; PATHOPHYSIOLOGY; REVIEW; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0031954920     PISSN: 01973118     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101:502-507.
2. Nand S, Wong W, Yuen B, et al Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol. 1997;56:12-16
3. Raskob G, George J. Thrombotic complications of antithrombotic therapy: A paradox with implications for clinical practice. Ann Intern Med 1997;127:839-840.
4. Scully RE, Mark E, McNeely W, et al. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 49-1989. N Engl J Med. 1989;32:1595-1603.
5. Visentin GP, Ford SE, Scott JP, et al. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest. 1994;93:81-88.
6. Weissmann R, Tobin R. Arterial embolism occurring during systemic heparin therapy. Arch Surg. 1979;114:372-377.
7. Warkentin T, Elavathil L, Hayward C, et al. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med. 1997;127:804-812.
8. Look KA, Sahud M, Flaherty S, et al. Heparin-induced platelet aggregation vs. platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis. Am J Clin Pathol. 1997; 108:78-82.
9. Chong BH, Burgess J, Ismail F The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost. 1993;69:344-350.
10. Arepally G, Reynolds C, Tomaski A, et al. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol. 1995;104:648-654.
11. Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases. Thromb Haemost. 1995;73:21-28.
12. ® (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Semin Thromb Hemost. 1997;23:197-202.
13. Edmunds LH Jr. HIT, HITT, and desulfatohirudin: Look before you leap. J Thorac Cardiovasc Surg. 1995;110:1-3.
14. Chong BH, Magnani HN. Orgaran in heparin-induced thrombocytopenia. Haemostasis. 1992;22:85-91.
15. Magnani HN. Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172). Thromb Haemost. 1993;70:554-561.
16. Danhof M, de Boer A, Magnani HN, et al. Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Haemostasis. 1992;22:73-84.
17. Bell WR. Heparin-associated thrombocytopenia and thrombosis. J Lab Clin Med. 1988;111:600-605.
18. Cofrancesco E, Colombi M, Fowst C, et al. Heparin-induced platelet aggregation and its inhibition by antagonists of the thromboxane pathway. Thromb Res. 1986;42:867-868.
19. Gruel Y, Lermusiaux P, Lang M, et al. Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis. Ann Vasc Surg. 1991;5:552-555.
20. Demers C, Ginsberg JS, Brill-Edwards P, et al. Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood. 1991;78:2194-2197.
21. Coulon M, Goffette P, Dondelinger RF. Local thrombolytic infusion in arterial ischemia of the upper limb: Mid-term results. Cardiovasc Intervent Radiol 1994;17:81-86.
22. Mehta DP, Yoder EL, Appel J, et al. Heparin-induced thrombocytopenia and thrombosis: Reversal with streptokinase. A case report and review of literature. Am J Hematol 1991;36:275-279.
23. Warkentin TE, Levine MN, Hirsh J. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332: 1330-1335.
24. Hussey CV, Bernhard VM, McLean MR, et al. Heparin-induced platelet aggregation: In vitro confirmation of thrombotic complications associated with heparin therapy. Ann Clin Lab Sci. 1979;9:487-493.
25. Olinger GN, Hussey CV, Olive JA, et al. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation. J Thorac Cardiovasc Surg. 1984; 87:673-677.